Cart summary

You have no items in your shopping cart.

Recombinant Cyclin-Dependent Kinase Inhibitor 2A (rHuP16-INK4a)

Recombinant Cyclin-Dependent Kinase Inhibitor 2A (rHuP16-INK4a)

Catalog Number: orb1495070

DispatchUsually dispatched within 5-10 working days
Contact us for a quotation
Catalog Numberorb1495070
CategoryProteins
DescriptionCyclin-dependent kinase inhibitors (CDKIs) are proteins that bind to and inhibit the activity of CDKs. Two major classes of CDK inhibitors have been identified. The p16 family (p15, p16, p18 and p19) binds to and inhibits the activities of CDK4 and CDK6. The p21 family (p21, p27, p28 and p57) can bind to broad range of CDK-cyclin complexes and inhibit their activities. CDKIs are capable of suppressing growth, and several lines of evidence strongly suggest that at least some CDKIs may be tumor suppressor proteins.
Form/AppearanceLyophilized from a 0.2mm filtered concentrated solution in PBS, pH 7.4.
Purity> 95% by SDS-PAGE and HPLC analyses.
MWApproximately 16.5 kDa, a single non-glycosylated polypeptide chain containing 156 amino acids.
Protein SequenceMEPAAGSSMEPSADWLATAAARGRVEEVRALLEAGALPNAPNSYGRRPIQVMMMGSARVAELLLLHGAEPNCADPATLTRPVHDAAREGFLDTLVVLHRAGARLDVRDAWGRLPVDLAEE LGHRDVARYL RAAAGGTRGS NHARIDAAEG PSDIPD
SourceEscherichia coli
Biological ActivityData Not Available.
EndotoxinsLess than 1EU/mg of rHuP16 as determined by LAL method.
StorageThis lyophilized preparation is stable at 2-8°C, but should be kept at -20°C for long term storage, preferably desiccated. Upon reconstitution, the preparation is stable for up to one week at 2-8°C. For maximal stability, apportion the reconstituted preparation into working aliquots and store at -20°C to -70°C. Avoid repeated freeze/thaw cycles.
Buffer/PreservativesLyophilized from a 0.2mm filtered concentrated solution in PBS, pH 7.4.
NoteFor research use only
Application notesWe recommend that this vial be briefly centrifuged prior to opening to bring the contents to the bottom. Reconstitute in sterile distilled water or aqueous buffer containing 0.1% BSA to a concentration of 0.1-1.0 mg/mL. Stock solutions should be apportioned into working aliquots and stored at < -20°C. Further dilutions should be made in appropriate buffered solutions.
Expiration Date6 months from date of receipt.
  • Human p16-INK4a-TAT protein [orb107793]

    HPLC,  SDS-PAGE

    Unconjugated

    > 95% by SDS-PAGE and HPLC analyses.

    18.0 kDa

    5 μg, 100 μg, 500 μg